Feb 7, 2025 08:05AM
Feb 7, 2025 08:05AM
Dec 11, 2024 07:00AM
Nov 14, 2024 08:05AM
Nov 6, 2024 07:14PM
Sep 5, 2024 09:05AM
Sep 5, 2024 09:05AM Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1)
Aug 26, 2024 05:03AM
Aug 15, 2024 09:00AM
May 30, 2024 09:00AM
May 16, 2024 08:05AM
Mar 18, 2024 09:05AM
Dec 27, 2023 04:15PM
Dec 18, 2023 09:15AM Cyclo Therapeutics (CYTH) Reports Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol Cyclo
Dec 18, 2023 09:15AM
Sep 28, 2022 02:03PM
Sep 28, 2022 02:02PM
Aug 16, 2022 08:05AM
May 12, 2022 04:05PM
Mar 29, 2022 08:35AM
Mar 14, 2022 08:06AM Cyclo Therapeutics (CYTH) Reports FY 21 Results, Provides Business Update
Mar 14, 2022 08:05AM
Feb 8, 2022 08:05AM
Dec 6, 2021 08:08AM
Dec 6, 2021 08:05AM
Nov 16, 2021 08:06AM
Nov 16, 2021 08:05AM
Nov 15, 2021 04:20PM Cyclo Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
Nov 2, 2021 08:05AM
Oct 6, 2021 08:05AM
Sep 27, 2021 08:09AM
Sep 27, 2021 08:05AM
Aug 17, 2021 08:05AM
Jul 27, 2021 08:05AM
Jun 17, 2021 08:05AM Cyclo Therapeutics Commences Patient Enrollment in TransportNPC, a Pivotal Phase 3 Study Evaluating Trappsol® Cyclo™ in Niemann-Pick Type C1
Jun 15, 2021 08:05AM
May 20, 2021 09:05AM
May 17, 2021 09:05AM
Apr 27, 2021 09:07AM
Apr 27, 2021 09:05AM
Apr 20, 2021 09:25AM
Mar 9, 2021 09:07AM Cyclo Therapeutics (CYTH) Receives Positive Opinion from Paediatric Committee of EMA on Agreement of Paediatric Investigation Plan for Trappsol Cyclo
Mar 9, 2021 09:05AM
Feb 22, 2021 09:03AM
Feb 22, 2021 09:00AM
Jan 5, 2021 08:04AM
Jan 5, 2021 08:00AM

322,094 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All